Cancer Institute– A national cancer institute
designated cancer center

Frank E. Stockdale

Back to Profile

Publication Details

  • New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.

    Kohrt HE, Olshen RA, Bermas HR, Goodson WH, Wood DJ, Henry S, Rouse RV, Bailey L, Philben VJ, Dirbas FM, Dunn JJ, Johnson DL, Wapnir IL, Carlson RW, Stockdale FE, Hansen NM, Jeffrey SS. BMC Cancer. 2008: 8 66

    Current practice is to perform a completion axillary lymph node dissection (ALND) for breast cancer patients with tumor-involved sentinel lymph nodes (SLNs), although fewer than half will have non-sentinel node (NSLN) metastasis. Our goal was to develop new models to quantify the risk of NSLN metastasis in SLN-positive patients and to compare predictive capabilities to another widely used model.

    PubMedID: 18315887

Stanford Medicine Resources:

Footer Links: